Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma-Reference-Cited by-同舟云学术

Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma

Published:2009-01 Issue:1 Volume:1 Page:31-40
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Alinari Lapo,White Valerie L.,Earl Christian T.,Ryan Timothy P.,Johnston Jeffrey S.,Dalton James T.,Ferketich Amy K.,Lai Raymond,Lucas David M.,Porcu Pierluigi,Blum Kristie A.,Byrd John C.,Baiocchi Robert A.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.1.1.7472

Reference53 articles.

1. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

2. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

3. Mantle cell lymphoma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GSK-J4 Inhibition of KDM6B Histone Demethylase Blocks Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells by Modulating NF-κB Signaling;Cells;2023-08-06

2. Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL;Blood Advances;2023-03-01

3. Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial;Clinical Lymphoma Myeloma and Leukemia;2021-03

4. NF-κB signaling promotes castration-resistant prostate cancer initiation and progression;Pharmacology & Therapeutics;2020-07

5. THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES;Mediterranean Journal of Hematology and Infectious Diseases;2019-06-25